Jonathan W. Friedberg, MD, on Managing Indolent NHL With Oral Therapies

August 12, 2021 By The ASCO Post Staff

Jonathan W. Friedberg, MD, of the University of Rochester Medical Center, discusses treatment options for follicular lymphoma, focusing on the combination of lenalidomide and rituximab and why he uses that regimen for first relapse but not front-line therapy.

Related Content